"Drew is a results-oriented collaborator who brings a positive approach to frame and address Business Development (BD) opportunities and challenges. I had the pleasure to collaborate closely with Drew for several months after hiring him as a BD consultant to Viking Therapeutics. Drew astutely leverages a scientific and financial acumen, coupled with hands-on practicality to deliver value added tools, such as a Strategic Target Map (that included H,M,L prioritization), a master Q&A document across clinical and pre-clinical assets, an optimized and granular Partnering Tracker, as well as various market and competitive analysis."